nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CYCS—adrenal medulla—adrenal gland cancer	0.13	0.331	CbGeAlD
Minocycline—CASP3—adrenal medulla—adrenal gland cancer	0.111	0.283	CbGeAlD
Minocycline—SLC22A8—urine—adrenal gland cancer	0.0145	0.0368	CbGeAlD
Minocycline—CASP1—gonad—adrenal gland cancer	0.0108	0.0275	CbGeAlD
Minocycline—CASP3—adrenal cortex—adrenal gland cancer	0.0108	0.0274	CbGeAlD
Minocycline—CASP1—pituitary gland—adrenal gland cancer	0.0105	0.0268	CbGeAlD
Minocycline—CYCS—gonad—adrenal gland cancer	0.0104	0.0265	CbGeAlD
Minocycline—CASP1—adrenal gland—adrenal gland cancer	0.00942	0.024	CbGeAlD
Minocycline—CYCS—adrenal gland—adrenal gland cancer	0.00907	0.0231	CbGeAlD
Minocycline—CASP3—gonad—adrenal gland cancer	0.00891	0.0227	CbGeAlD
Minocycline—CASP3—pituitary gland—adrenal gland cancer	0.0087	0.0221	CbGeAlD
Minocycline—VEGFA—adrenal cortex—adrenal gland cancer	0.00846	0.0215	CbGeAlD
Minocycline—CASP3—adrenal gland—adrenal gland cancer	0.00777	0.0198	CbGeAlD
Minocycline—VEGFA—cardiac atrium—adrenal gland cancer	0.00699	0.0178	CbGeAlD
Minocycline—IL1B—pituitary gland—adrenal gland cancer	0.00695	0.0177	CbGeAlD
Minocycline—VEGFA—pituitary gland—adrenal gland cancer	0.00683	0.0174	CbGeAlD
Minocycline—IL1B—adrenal gland—adrenal gland cancer	0.00621	0.0158	CbGeAlD
Minocycline—VEGFA—adrenal gland—adrenal gland cancer	0.0061	0.0155	CbGeAlD
Minocycline—MMP9—adrenal gland—adrenal gland cancer	0.00517	0.0132	CbGeAlD
Minocycline—ALOX5—adrenal gland—adrenal gland cancer	0.00409	0.0104	CbGeAlD
Minocycline—CASP3—Copper homeostasis—TP53—adrenal gland cancer	0.00108	0.00179	CbGpPWpGaD
Minocycline—CYCS—DNA Damage Response—TP53—adrenal gland cancer	0.00108	0.00179	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00108	0.00179	CbGpPWpGaD
Minocycline—CYCS—p75(NTR)-mediated signaling—TP53—adrenal gland cancer	0.00107	0.00177	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PRKACA—adrenal gland cancer	0.00107	0.00176	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TP53—adrenal gland cancer	0.00107	0.00176	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.00107	0.00176	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.00107	0.00176	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—adrenal gland cancer	0.00106	0.00175	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.00106	0.00174	CbGpPWpGaD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—TP53—adrenal gland cancer	0.00105	0.00173	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00105	0.00173	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—RB1—adrenal gland cancer	0.00104	0.00172	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—BAD—adrenal gland cancer	0.00103	0.00171	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.00103	0.0017	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00101	0.00167	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—CDKN2A—adrenal gland cancer	0.00101	0.00166	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—TP53—adrenal gland cancer	0.001	0.00165	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—TP53—adrenal gland cancer	0.000989	0.00163	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—PRKACA—adrenal gland cancer	0.000986	0.00162	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SDHB—adrenal gland cancer	0.000973	0.0016	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TP53—adrenal gland cancer	0.000962	0.00159	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000962	0.00159	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by TCPTP—EGFR—adrenal gland cancer	0.000961	0.00158	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.000959	0.00158	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NR5A1—adrenal gland cancer	0.000951	0.00157	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000946	0.00156	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000945	0.00156	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00094	0.00155	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—SPARC—adrenal gland cancer	0.000939	0.00155	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—adrenal gland cancer	0.000916	0.00151	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000914	0.00151	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.000912	0.0015	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00091	0.0015	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	0.000908	0.0015	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.000893	0.00147	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PRKACA—adrenal gland cancer	0.000885	0.00146	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—BRAF—adrenal gland cancer	0.000883	0.00146	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000876	0.00144	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—TP53—adrenal gland cancer	0.000875	0.00144	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—TP53—adrenal gland cancer	0.000865	0.00143	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TP53—adrenal gland cancer	0.000859	0.00142	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000859	0.00142	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000857	0.00141	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—EGFR—adrenal gland cancer	0.000847	0.0014	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—TP53—adrenal gland cancer	0.000846	0.00139	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—CTNNB1—adrenal gland cancer	0.000844	0.00139	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TP53—adrenal gland cancer	0.000812	0.00134	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.000802	0.00132	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—BRAF—adrenal gland cancer	0.000799	0.00132	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—RB1—adrenal gland cancer	0.000799	0.00132	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—adrenal gland cancer	0.000793	0.00131	CbGpPWpGaD
Minocycline—IL1B—Immune System—SH3KBP1—adrenal gland cancer	0.000781	0.00129	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TP53—adrenal gland cancer	0.000776	0.00128	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—BAD—adrenal gland cancer	0.000775	0.00128	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—EGFR—adrenal gland cancer	0.00076	0.00125	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CDC42—adrenal gland cancer	0.000759	0.00125	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CDC42—adrenal gland cancer	0.00075	0.00124	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—RB1—adrenal gland cancer	0.000749	0.00123	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.000741	0.00122	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—adrenal gland cancer	0.000739	0.00122	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000732	0.00121	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000728	0.0012	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000722	0.00119	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—EGFR—adrenal gland cancer	0.000714	0.00118	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—adrenal gland cancer	0.000711	0.00117	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000709	0.00117	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—IGF1R—adrenal gland cancer	0.000708	0.00117	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—adrenal gland cancer	0.000703	0.00116	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.000695	0.00115	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—adrenal gland cancer	0.000693	0.00114	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—CTNNB1—adrenal gland cancer	0.000681	0.00112	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000677	0.00112	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000673	0.00111	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000671	0.00111	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.000659	0.00109	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MED12—adrenal gland cancer	0.000658	0.00108	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000657	0.00108	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000648	0.00107	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000647	0.00107	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000644	0.00106	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000637	0.00105	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—BAD—adrenal gland cancer	0.000634	0.00104	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SDHD—adrenal gland cancer	0.000627	0.00103	CbGpPWpGaD
Minocycline—CYCS—Metabolism—RRM1—adrenal gland cancer	0.000627	0.00103	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000615	0.00101	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000613	0.00101	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000607	0.001	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNRHR—adrenal gland cancer	0.0006	0.000989	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SDHB—adrenal gland cancer	0.000599	0.000988	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—adrenal gland cancer	0.000594	0.000979	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00059	0.000972	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.00058	0.000955	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000579	0.000954	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—BRAF—adrenal gland cancer	0.000577	0.000951	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000576	0.000949	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MED12—adrenal gland cancer	0.000571	0.000941	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—CDC42—adrenal gland cancer	0.000571	0.00094	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.00057	0.000939	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—adrenal gland cancer	0.000563	0.000928	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—adrenal gland cancer	0.000561	0.000925	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	0.00056	0.000922	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000558	0.000919	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	0.000552	0.000909	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000551	0.000908	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	0.000547	0.000901	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—adrenal gland cancer	0.000539	0.000888	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—BAD—adrenal gland cancer	0.00053	0.000873	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000528	0.00087	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000525	0.000865	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—BAD—adrenal gland cancer	0.000524	0.000863	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—CTNNB1—adrenal gland cancer	0.000521	0.000858	CbGpPWpGaD
Minocycline—CASP1—Immune System—PRKACA—adrenal gland cancer	0.000515	0.000849	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—adrenal gland cancer	0.00051	0.00084	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000506	0.000833	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—CDC42—adrenal gland cancer	0.000495	0.000816	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SPARC—adrenal gland cancer	0.000484	0.000798	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—BRAF—adrenal gland cancer	0.000482	0.000795	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000472	0.000777	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MED12—adrenal gland cancer	0.000467	0.00077	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000466	0.000767	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000462	0.000762	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000458	0.000754	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000456	0.000752	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—adrenal gland cancer	0.000453	0.000746	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDC42—adrenal gland cancer	0.000437	0.00072	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000425	0.0007	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.000419	0.00069	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNRHR—adrenal gland cancer	0.000417	0.000687	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PRKACA—adrenal gland cancer	0.000409	0.000674	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000408	0.000673	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CDC42—adrenal gland cancer	0.000407	0.000671	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—adrenal gland cancer	0.000404	0.000666	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—adrenal gland cancer	0.000391	0.000644	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000388	0.000639	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000387	0.000638	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SDHD—adrenal gland cancer	0.000386	0.000636	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—RRM1—adrenal gland cancer	0.000386	0.000636	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000384	0.000633	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000383	0.000631	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000377	0.000622	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—adrenal gland cancer	0.000367	0.000604	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—RB1—adrenal gland cancer	0.000364	0.0006	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000364	0.0006	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNRHR—adrenal gland cancer	0.000362	0.000596	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00036	0.000593	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CDC42—adrenal gland cancer	0.000354	0.000583	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CTNNB1—adrenal gland cancer	0.000349	0.000574	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000347	0.000572	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CDC42—adrenal gland cancer	0.000347	0.000571	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CTNNB1—adrenal gland cancer	0.000344	0.000568	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000343	0.000564	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PRKACA—adrenal gland cancer	0.000341	0.000562	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000336	0.000554	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IGF2—adrenal gland cancer	0.000334	0.000551	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000332	0.000547	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GNAS—adrenal gland cancer	0.000331	0.000546	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—adrenal gland cancer	0.00033	0.000544	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000329	0.000542	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRKACA—adrenal gland cancer	0.000322	0.000531	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TSHR—adrenal gland cancer	0.00032	0.000528	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.00032	0.000528	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000316	0.000521	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000306	0.000504	CbGpPWpGaD
Minocycline—CASP1—Immune System—BAD—adrenal gland cancer	0.000305	0.000503	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MEN1—adrenal gland cancer	0.000301	0.000497	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0003	0.000495	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MED12—adrenal gland cancer	0.000288	0.000474	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000288	0.000474	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000279	0.000459	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000278	0.000457	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GNAS—adrenal gland cancer	0.000276	0.000455	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—adrenal gland cancer	0.000276	0.000455	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000275	0.000453	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDC42—adrenal gland cancer	0.000273	0.00045	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—adrenal gland cancer	0.000273	0.00045	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000272	0.000449	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ABCB1—adrenal gland cancer	0.000271	0.000447	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000257	0.000424	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNRH1—adrenal gland cancer	0.00025	0.000411	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00024	0.000396	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000233	0.000385	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000231	0.000381	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00023	0.000379	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000229	0.000377	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SPRY2—adrenal gland cancer	0.000228	0.000376	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TSHR—adrenal gland cancer	0.000222	0.000367	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNRH1—adrenal gland cancer	0.000217	0.000357	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PRKACA—adrenal gland cancer	0.00021	0.000346	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MEN1—adrenal gland cancer	0.000209	0.000345	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—adrenal gland cancer	0.000208	0.000342	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000205	0.000338	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTNNB1—adrenal gland cancer	0.000201	0.000331	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SPRY2—adrenal gland cancer	0.000198	0.000327	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDC42—adrenal gland cancer	0.000195	0.000321	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000195	0.000321	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TSHR—adrenal gland cancer	0.000193	0.000318	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000191	0.000315	CbGpPWpGaD
Minocycline—IL1B—Immune System—BAD—adrenal gland cancer	0.000191	0.000314	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF2—adrenal gland cancer	0.000188	0.00031	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CTNNB1—adrenal gland cancer	0.000187	0.000308	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNAS—adrenal gland cancer	0.000186	0.000307	CbGpPWpGaD
Minocycline—CYCS—Metabolism—POMC—adrenal gland cancer	0.000186	0.000307	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000182	0.0003	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MEN1—adrenal gland cancer	0.000182	0.000299	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—adrenal gland cancer	0.00018	0.000297	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—adrenal gland cancer	0.000178	0.000294	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNAS—adrenal gland cancer	0.00017	0.000281	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCB1—adrenal gland cancer	0.000167	0.000275	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CTNNB1—adrenal gland cancer	0.000162	0.000267	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKACA—adrenal gland cancer	0.00016	0.000263	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—adrenal gland cancer	0.000159	0.000262	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TERT—adrenal gland cancer	0.000157	0.000258	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—adrenal gland cancer	0.000148	0.000245	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—adrenal gland cancer	0.000148	0.000244	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKACA—adrenal gland cancer	0.000139	0.000228	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BAD—adrenal gland cancer	0.000136	0.000224	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDC42—adrenal gland cancer	0.000135	0.000223	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF2—adrenal gland cancer	0.000131	0.000215	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNAS—adrenal gland cancer	0.000129	0.000213	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—adrenal gland cancer	0.000129	0.000212	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1R—adrenal gland cancer	0.000126	0.000208	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—adrenal gland cancer	0.000126	0.000207	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTNNB1—adrenal gland cancer	0.000125	0.000207	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BRAF—adrenal gland cancer	0.000124	0.000204	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDC42—adrenal gland cancer	0.000118	0.000194	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—adrenal gland cancer	0.000115	0.000189	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF2—adrenal gland cancer	0.000113	0.000187	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNAS—adrenal gland cancer	0.000112	0.000185	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1R—adrenal gland cancer	0.00011	0.000181	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TERT—adrenal gland cancer	0.000109	0.000179	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—adrenal gland cancer	0.000106	0.000175	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—adrenal gland cancer	9.93e-05	0.000164	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BAD—adrenal gland cancer	9.45e-05	0.000156	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TERT—adrenal gland cancer	9.43e-05	0.000155	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—adrenal gland cancer	9.14e-05	0.000151	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CTNNB1—adrenal gland cancer	8.96e-05	0.000148	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—adrenal gland cancer	8.71e-05	0.000144	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BRAF—adrenal gland cancer	8.6e-05	0.000142	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BAD—adrenal gland cancer	8.2e-05	0.000135	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—adrenal gland cancer	7.56e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BRAF—adrenal gland cancer	7.47e-05	0.000123	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—adrenal gland cancer	7.1e-05	0.000117	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CTNNB1—adrenal gland cancer	6.22e-05	0.000102	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—adrenal gland cancer	5.96e-05	9.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CTNNB1—adrenal gland cancer	5.4e-05	8.9e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—adrenal gland cancer	4.93e-05	8.12e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—adrenal gland cancer	4.28e-05	7.05e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—adrenal gland cancer	4.14e-05	6.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—adrenal gland cancer	3.59e-05	5.92e-05	CbGpPWpGaD
